Hana Biosciences (NASDAQ: HNAB) 34.2% LOWER; Provided an update on the company's pipeline: Marqibo - Hana is no longer pursuing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE